Healthcare is the largest sector of the US economy at over $4 trillion in annual spending — and one of the most active categories for venture capital investment. Despite the complexity of healthcare markets (long sales cycles, regulatory hurdles, reimbursement challenges), investors continue to pour capital into companies digitizing care delivery, improving drug discovery, and reducing administrative costs.
Global digital health investment reached $15.3 billion in 2023, even after the significant contraction from 2021 highs. The investors who are still writing checks in healthcare are highly selective and deeply specialized. Here is who they are.
The Healthcare VC Landscape
Healthcare investing breaks into several distinct sub-categories, and most investors specialize in one or two:
- Digital health / health tech: SaaS and consumer apps for patients and providers
- Biotech / biopharma: Drug discovery, genomics, diagnostics
- Health services: Value-based care, care delivery, home health
- Healthcare infrastructure: Revenue cycle management, EHR interoperability, insurance tech
- Medical devices: Hardware, robotics, surgical tools
Top VC Firms in Healthcare
1. Andreessen Horowitz (a16z Bio)
Stage: Seed–Series C | Check size: $2M–$50M
a16z has a dedicated bio fund that invests across biotech, health tech, and healthcare services. Their bio team includes former scientists, physicians, and operators. Portfolio includes Carbon Health, Devoted Health, and Honor.
2. GV (Google Ventures)
Stage: Seed–Series B | Check size: $1M–$20M
GV is one of the most active healthcare investors globally, with a portfolio spanning life sciences, digital health, and health infrastructure. Notable investments include Foundation Medicine, Flatiron Health (acquired by Roche), and Oscar Health.
3. Rock Health
Stage: Seed–Series A | Check size: $500K–$5M
Rock Health is the leading seed-stage fund dedicated exclusively to digital health. They have funded 200+ digital health companies and are the default first institutional investor for many health tech founders. Their annual Digital Health Funding report is required reading for anyone in the space.
4. OrbiMed
Stage: Series A–C | Check size: $10M–$100M
OrbiMed manages over $18 billion in assets and is the world's largest dedicated healthcare investment firm. They invest across public and private markets, with a focus on biotech, medical devices, and healthcare services. Their global footprint (New York, San Francisco, Tel Aviv, Mumbai) makes them ideal for companies with international ambitions.
5. General Catalyst
Stage: Seed–Growth | Check size: $3M–$100M
General Catalyst has made healthcare one of their primary focus areas, investing in health assurance companies — businesses that make people healthier, not just treat them when they are sick. Portfolio includes Livongo (IPO), Oscar Health, and Cityblock Health.
What Healthcare VCs Look For
- Regulatory pathway: FDA clearance strategy, reimbursement plan, compliance framework
- Clinical evidence: RCT data, published outcomes, peer-reviewed research
- Distribution moat: How do you get into health systems? Who is your economic buyer?
- Payor dynamics: Who pays? Employer, Medicare/Medicaid, out-of-pocket? What is the reimbursement code?
- Team credentials: MD/PhD on the team? Relationships with KOLs (key opinion leaders)?
Find Healthcare Investors on VC Sift
Filter VC Sift by the Healthcare sector to surface thousands of verified investors — from early-stage angels to growth equity firms — who have specifically funded healthcare companies. Each profile includes verified email addresses and LinkedIn profiles for direct outreach.